To address this issue, we injected BrdU daily to identify newly formed cells generated 3-10 days following ischemia, and then co-immunostained for BrdU and CD31 to identify mature vessels present at 56 days after stroke (Fig. 3A, B). The gene discussed is PECAM1; the disease is stroke disorder.